Home » News » New York equities outlook: cautious start

New York equities outlook: cautious start

NEW YORK (dpa-AFX) – An initially restrained start to trading is emerging on the US stock exchanges in the middle of the week. A good half an hour before the start, the broker IG assessed the leading index Dow Jones Industrial with a price premium of 0.18 percent at 34,640 points. The tech-heavy Nasdaq 100 IG also sees it only moderately with a plus of 0.10 percent at 13,668 points.

The day before, the US stock exchanges, which had started trading again for the first time after the long weekend, quickly lost their initial momentum despite good US sentiment data. The Dow brought only a small plus over the finish line, while the other indices closed in the red. Investors, it was said in the market, are currently maneuvering between hopes of a strong economic recovery and worries that inflation will rise too sharply, which could force the US Federal Reserve to take countermeasures in interest rates.

The players in the market were therefore now waiting for further signals as to whether the US monetary authorities could curb their support measures. While all eyes are already on the official labor market report due on Friday, attention should therefore also be paid to the Fed’s economic report due on Wednesday evening. Otherwise, the day should turn out to be quite calm, at least on the economic agenda.

On the corporate side, the papers of the video conferencing service Zoom were in demand with investors before the trading day, but they have recently been back a little. The company continues to grow rapidly thanks to the corona pandemic and was able to multiply its profit in the first quarter, so that Zoom also exceeded the expectations of the analysts.

Zoom was one of the stragglers of the reporting season, which is now almost over. In the middle of the week, Advance Auto Parts presented its figures for the past quarter in the back rows of the stock market, while the supplier of automotive spare parts raised its outlook for the year as a whole.

The US biotech company Constellation Pharmaceuticals is meanwhile about to be taken over by the German MDax -Corporation Morphosys. The Bavarians are offering $ 34 in cash per share, making the deal worth $ 1.7 billion. Before the trading day, many investors quickly jumped on the bandwagon and secured Constellation shares: The price of the Americans rose by more than 67 percent and most recently approached the offered purchase price.

While oil companies such as Chevron and ExxonMobil should still be worth a look because of the soaring oil price, the AMC shares popular among US retail investors organized on the Internet jumped by more than 20 percent to a new record. The cinema chain had only sold shares to the investment company Mudrick Capital Management the day before at a high premium, taking in around $ 230 million.

– .

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.